Exsymol targets the eye contour with a dedicated set of three active ingredients
On the occasion of the Global Cosmetics Exhibition, which will be held in Paris from 16 to 18 April 2024, the Monaco-based manufacturer focuses on the eye area, launching a set of three active ingredients.
The most important of these is that Exsymol will launch for the first time Prolistin, a 100% naturally derived peptide (synthesized from biologically fermented amino acids) with anti-inflammatory and melanin-inhibiting effects. Prolistin captures pro-inflammatory free copper to target the three main symptoms associated with eye contour (dark circles, eye bags, and signs of aging) for 360° eye contour care.
Coffeesilane, the second active ingredient, is a silanol. Best known for its body-sculpting effects, it's also effective at treating dark circles and puffiness, as are Meyanol and upgraded elderberry extract, which make up the third item in the new Eye Contour Kit.
2026-10-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
DKSH signs exclusive Canadian distribution agreement with cosmetic active ingredients manufacturer Exsymol
-
Indonesia’s Plastic Prices Jump 50%–100% as Government Moves to Remove Import Duties
-
Butadiene Rubber's Cost in China Floor Collapses, Exports Hold the Line
-
LG Chem Teams Up with Jianghua Microelectronics to Advance Semiconductor Ultra-High-Purity IPA
-
ExxonMobil’s 264,000-bpd Joliet Refinery Shuts After Site-Wide Power Failure
-
Ammonia Leaks in Iraq and Jordan Put Fertilizer Production and Port Safety on Alert
-
Middle East Conflict Hits the Electronics Supply Chain as PPE Resin Shortage Sends PCB Prices Up 40%
-
UAE Withdraws from OPEC
-
Chemical Tanker Explodes Off Oman Coast, Maritime Security Risk Escalates Again
Recommend Reading
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
$530 Million Lawsuit Unheard, $76 Million Counterclaim Filed: Is Qicai Chemical’s ‘Reputation Defense’ a Desperate Last Stand or a Calculated PR Gambit?
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Business Society September 24, 2026 DOP Trend Analysis: Clear Decline
-
This Week’s Ethyl Acetate Market Continues to Decline
-
Business Society’s August 19, 2026 Methanol Market Outlook: Clearly Upward Trend
-
Business Society September 23, 2026 Maleic Anhydride Trend Analysis: Volatility
-
Monthly Plunge Exceeds 20%! Melamine Prices Break Through 7,500 Yuan, When Will the Market Hit Bottom?